Sarepta Therapeutics(SRPT) - 2021 Q2 - Earnings Call Transcript

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q2 2018 Results Conference Call August 4, 2021 4:30 PM ET Company Participants Mary Jenkins - Senior Manager, IR Doug Ingram - President and CEO Ian Estepan - EVP and CFO Dallan Murray - SVP and Chief Commercial Officer Dr. Gilmore O’Neill - EVP, R&D and Chief Medical Officer Dr. Louise Rodino-Klapac - EVP and Chief Scientific Officer Conference Call Participants Gena Wang - Barclays Tazeen Ahmad - BoA Brian Abrahams - RBC Capital Markets Alethia Young - Cantor Anupa ...